Literature DB >> 17980746

Bevacizumab and retinal ischemia.

Aljoscha S Neubauer, Daniel Kook, Christos Haritoglou, Siegfried G Priglinger, Anselm Kampik, Michael W Ulbig, Lala Ceklic.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17980746     DOI: 10.1016/j.ophtha.2007.05.057

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


× No keyword cloud information.
  11 in total

1.  Effects of intravitreal bevacizumab treatment on proliferative retinopathy in a patient with cerebroretinal vasculopathy.

Authors:  Marcus Kernt; Andreas Gschwendtner; Aljoscha S Neubauer; Martin Dichgans; Christos Haritoglou
Journal:  J Neurol       Date:  2010-02-24       Impact factor: 4.849

Review 2.  [Diabetic maculopathy].

Authors:  C Haritoglou; M Kernt; A Wolf
Journal:  Ophthalmologe       Date:  2015-10       Impact factor: 1.059

Review 3.  Disentangling the association between retinal non-perfusion and anti-VEGF agents in diabetic retinopathy.

Authors:  Irini Chatziralli; Sara Touhami; Maria Vittoria Cicinelli; Chrysa Agapitou; Eleni Dimitriou; George Theodossiadis; Panagiotis Theodossiadis
Journal:  Eye (Lond)       Date:  2021-08-18       Impact factor: 3.775

Review 4.  Diabetic macular edema: what is focal and what is diffuse?

Authors:  David J Browning; Michael M Altaweel; Neil M Bressler; Susan B Bressler; Ingrid U Scott
Journal:  Am J Ophthalmol       Date:  2008-09-05       Impact factor: 5.258

5.  Insight into 144 patients with ocular vascular events during VEGF antagonist injections.

Authors:  Ahmad M Mansour; Maha Shahin; Peter K Kofoed; Maurizio B Parodi; Michel Shami; Stephen G Schwartz
Journal:  Clin Ophthalmol       Date:  2012-03-06

6.  Neovascular glaucoma after vitrectomy in patients with proliferative diabetic retinopathy.

Authors:  Jin-Woo Kwon; Donghyun Jee; Tae Yoon La
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

7.  Angiographically Documented Macular Ischemia after Single Bevacizumab for Macular Edema Secondary to Central Retinal Vein Occlusion.

Authors:  Kyou Ho Lee; Eui Chun Kang; Hyoung Jun Koh
Journal:  Yonsei Med J       Date:  2017-05       Impact factor: 2.759

8.  Diabetic Macular Edema Treatment with Bevacizumab Does Not Depend on the Retinal Nonperfusion Presence.

Authors:  Bogumiła Sędziak-Marcinek; Sławomir Teper; Elżbieta Chełmecka; Adam Wylęgała; Mateusz Marcinek; Mateusz Bas; Edward Wylęgała
Journal:  J Diabetes Res       Date:  2021-02-26       Impact factor: 4.011

9.  Changes in Macular Perfusion After ILUVIEN® Intravitreal Implant for Diabetic Macular Edema: An OCTA Study.

Authors:  Maria Brambati; Enrico Borrelli; Luigi Capone; Lea Querques; Riccardo Sacconi; Marco Battista; Francesco Bandello; Giuseppe Querques
Journal:  Ophthalmol Ther       Date:  2022-01-28

10.  Changes in the foveal microstructure after intravitreal bevacizumab application in patients with retinal vascular disease.

Authors:  Nikolaus Feucht; Etienne Michael Schönbach; Ines Lanzl; Konstantin Kotliar; Chris Patrick Lohmann; Mathias Maier
Journal:  Clin Ophthalmol       Date:  2013-01-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.